Hosted on MSN1mon
Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earningsContinue reading Spravato, which is derived from ketamine, is not a new drug—it ... Despite the approval, Johnson & Johnson’s stock (JNJ) dipped Wednesday after the company’s quarterly ...
Bryan Johnson is a biohacker on a mission to conquer death and has been injecting ketamine into his system to see how it ...
Bryan Johnson, the American entrepreneur renowned for his anti-ageing endeavours, has disclosed the details of his latest ...
Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.
In his quest to defy ageing, he has undergone unconventional and radical procedures, including receiving blood transfusions ...
Across Lancashire, recorded offences for possession and supply of ketamine rose by nearly 70% from 54 in 2023 to 91 in 2024. ...
Tech mogul Bryan Johnson, known for his radical anti-aging methods, admitted to injecting himself with Ketamine, a horse ...
Bryan Johnson, an American entrepreneur known for his anti-ageing experiments, recently revealed details of his latest ...
Spravato is a ketamine-derived nasal spray that is FDA-approved for treatment-resistant depression. The Johnson & Johnson drug has been on the market since 2019, but could only be prescribed ...
Bryan Johnson shared details of the study of his brain following the Ketamine injection. (X/@bryan_johnson) The entrepreneur, who created a huge buzz in India recently after he left billionaire ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results